Concepedia

Stacey Difuntorum

SD

6

Publications

280

Citations

6

H-Index

2002

Active since

Affiliations

Theravance Biopharma (United States)(Current)

Stacey Difuntorum is an author at Theravance Biopharma (United States) specializing in drug resistance, antimicrobial resistance, and medicine.

Top concepts

Publications per year

2002–2009

6

Publications

6

In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria

Kevin M. Krause, Marika Renelli, Stacey Difuntorum et al. · Antimicrobial Agents and Chemotherapy · 2008 · 97 citations · Full text

, , +14

DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 2: C-terminal benzimidazoles and derivatives

Roland W. Bürli, Peter Jones, Dustin L. McMinn et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 56 citations

, , +9

Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus

Sharath S Hegde, Noe Reyes, Robert Skinner et al. · Journal of Antimicrobial Chemotherapy · 2007 · 47 citations · Full text

In Vitro Antimicrobial Activity of GSQ1530, a New Heteroaromatic Polycyclic Compound

Yigong Ge, Stacey Difuntorum, Sofia M. Touami et al. · Antimicrobial Agents and Chemotherapy · 2002 · 32 citations · Full text

, , +16

DNA Binding Ligands with Improved in Vitro and in Vivo Potency against Drug-Resistant <i>Staphylococcus aureus</i>

Wenhao Hu, Roland W. Bürli, Jacob A. Kaizerman et al. · Journal of Medicinal Chemistry · 2004 · 25 citations

Rows per page

1–5 of 6